UBS Group’s Evotec EVO Stock Holding History
Bought
Maintained
Sold
Other funds holding EVO
MIC
DA
AA
UBS Group's EVO Position: Q1 2026 in Review
UBS Group opened a new position in Evotec (EVO) in Q1 2026: 1,501 shares worth $3.75K. The stake represents ﹤0.01% of the portfolio and ranks #9038 among its holdings. This is a return to the name: UBS Group previously reported a position in EVO as recently as Q3 2025.
UBS Group first reported a position in EVO in Q4 2021 and has held it in 17 quarters since. The position peaked at $82.8K in Q2 2023. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.
- UBS Group held 1,501 shares of Evotec worth $3.75K as of Q1 2026.
- Evotec was a new UBS Group position in Q1 2026.
- Evotec made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9038 holding.
- UBS Group first reported a position in Evotec in Q4 2021 and has held it in 17 quarters since.
- UBS Group's Evotec position peaked at $82.8K in Q2 2023.
- 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.